Tasos Konidaris sold $4.7M of Amneal Pharmaceuticals (AMRX)

Executed Aug 13 2025, disclosed Aug 15 2025, 2 days later.

Value, as filed

$4.7M

499,730 sh across 3 lots

Executed

Aug 13 2025

the trade date, as filed

Disclosed

Aug 15 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

TK Tasos Konidaris Executive Vice President & CFO profile →

Tasos Konidaris (Executive Vice President & CFO) filed 2 Form 4 reports in the past 24 months (0 purchases, 2 sales), most often in Amneal Pharmaceuticals, Inc. (AMRX). The largest single filing was $4.7M of AMRX (499,730 sh across 3 lots, as filed), executed Aug 13 2025.

The name

AMRX Amneal Pharmaceuticals, Inc. AMRX · Healthcare · 32 filings in 24 months ticker →

Healthcare · Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, b…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Tasos Konidaris in AMRX

AMRXSALE Amneal Pharmaceuticals, Inc. $891K
100,000 sh × $8.91
Exec Mar 5 2025
Filed Mar 7 2025 · 5:30 PM ET